
Delia M. Ramirez
Examiner (ID: 17488, Phone: (571)272-0938 , Office: P/1652 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1545 |
| Issued Applications | 838 |
| Pending Applications | 179 |
| Abandoned Applications | 542 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17611872
[patent_doc_number] => 20220154151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => NON-CANONICAL LIPOPROTEINS WITH PROGRAMMABLE ASSEMBLY AND ARCHITECTURE
[patent_app_type] => utility
[patent_app_number] => 17/529860
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/529860 | Non-canonical lipoproteins with programmable assembly and architecture and method of making non-canonical lipoproteins | Nov 17, 2021 | Issued |
Array
(
[id] => 20179800
[patent_doc_number] => 20250263758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => A CELL-FREE BIO-MANUFACTURING PLATFORM FOR PRODUCTION OF FATTY ACIDS AND CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 18/251604
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251604
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251604 | A CELL-FREE BIO-MANUFACTURING PLATFORM FOR PRODUCTION OF FATTY ACIDS AND CANNABINOIDS | Nov 1, 2021 | Pending |
Array
(
[id] => 18862272
[patent_doc_number] => 20230416708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => Novel Variants of Endonuclease V and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/033787
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033787 | Novel Variants of Endonuclease V and Uses Thereof | Oct 20, 2021 | Pending |
Array
(
[id] => 18972235
[patent_doc_number] => 20240052327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => METHOD OF CONTROLLING TOTAL SIALIC ACID CONTENT (TSAC) DURING MANUFACTURING OF ALKALINE PHOSPHATASE
[patent_app_type] => utility
[patent_app_number] => 18/032973
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032973
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032973 | METHOD OF CONTROLLING TOTAL SIALIC ACID CONTENT (TSAC) DURING MANUFACTURING OF ALKALINE PHOSPHATASE | Oct 20, 2021 | Pending |
Array
(
[id] => 17505191
[patent_doc_number] => 20220098293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => SPLIT INTEINS, CONJUGATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/491729
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491729 | Split inteins, conjugates and uses thereof | Sep 30, 2021 | Issued |
Array
(
[id] => 17444112
[patent_doc_number] => 20220064617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Recombinant Glycoproteins and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/482193
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482193 | Recombinant Glycoproteins and Uses Thereof | Sep 21, 2021 | Abandoned |
Array
(
[id] => 18701578
[patent_doc_number] => 11788077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
[patent_app_type] => utility
[patent_app_number] => 17/479173
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 34376
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479173
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479173 | Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome | Sep 19, 2021 | Issued |
Array
(
[id] => 17337440
[patent_doc_number] => 20220003771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => METHODS OF DETECTING A POLYPEPTIDE HAVING ANAPLASTIC LYMPHOMA KINASE ACTIVITY IN KIDNEY CANCER
[patent_app_type] => utility
[patent_app_number] => 17/479010
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479010
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479010 | METHODS OF DETECTING A POLYPEPTIDE HAVING ANAPLASTIC LYMPHOMA KINASE ACTIVITY IN KIDNEY CANCER | Sep 19, 2021 | Abandoned |
Array
(
[id] => 17314914
[patent_doc_number] => 20210403962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => MODIFIED HOMOSERINE DEHYDROGENASE AND METHOD FOR PRODUCING HOMOSERINE OR L-AMINO ACID DERIVED FROM HOMOSERINE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/472028
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472028 | Nucleic acid encoding a modified homoserine dehydrogenase | Sep 9, 2021 | Issued |
Array
(
[id] => 18879523
[patent_doc_number] => 20240002892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => COMPOUND ENZYME AND APPLICATION THEREOF IN PREPARATION OF L-ERGOTHIONEINE
[patent_app_type] => utility
[patent_app_number] => 18/035281
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035281
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035281 | COMPOUND ENZYME AND APPLICATION THEREOF IN PREPARATION OF L-ERGOTHIONEINE | Sep 8, 2021 | Pending |
Array
(
[id] => 18675625
[patent_doc_number] => 20230313243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => Novel O-Phosphoserine Export Protein and Methods for Producing O-Phosphoserine, Cysteine, and Cysteine Derivative Using Same
[patent_app_type] => utility
[patent_app_number] => 18/023462
[patent_app_country] => US
[patent_app_date] => 2021-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023462
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023462 | Novel O-Phosphoserine Export Protein and Methods for Producing O-Phosphoserine, Cysteine, and Cysteine Derivative Using Same | Sep 5, 2021 | Pending |
Array
(
[id] => 17533864
[patent_doc_number] => 20220112473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ENGINEERED PROTEINS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/459166
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17459166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/459166 | ENGINEERED PROTEINS AND METHODS OF USE THEREOF | Aug 26, 2021 | Pending |
Array
(
[id] => 17460583
[patent_doc_number] => 20220073888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => COMBINATION TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/405670
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405670 | COMBINATION TREATMENT | Aug 17, 2021 | Abandoned |
Array
(
[id] => 17399935
[patent_doc_number] => 20220042025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => COMPOSITIONS AND METHODS FOR CONVERTING STYRENE TO BIODEGRADABLE ALTERNATIVES
[patent_app_type] => utility
[patent_app_number] => 17/396381
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396381 | COMPOSITIONS AND METHODS FOR CONVERTING STYRENE TO BIODEGRADABLE ALTERNATIVES | Aug 5, 2021 | Pending |
Array
(
[id] => 17385977
[patent_doc_number] => 20220033829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => PEPTIDE BARCODES FOR CORRELATING NUCLEIC ACID-GUIDED NUCLEASE OR NICKASE FUSION EDITING AND PROTEIN TRANSLATION IN A POPULATION OF CELLS
[patent_app_type] => utility
[patent_app_number] => 17/387780
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17387780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/387780 | PEPTIDE BARCODES FOR CORRELATING NUCLEIC ACID-GUIDED NUCLEASE OR NICKASE FUSION EDITING AND PROTEIN TRANSLATION IN A POPULATION OF CELLS | Jul 27, 2021 | Abandoned |
Array
(
[id] => 18085545
[patent_doc_number] => 11535663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
[patent_app_type] => utility
[patent_app_number] => 17/383322
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 86
[patent_no_of_words] => 67695
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/383322 | Methods for producing aflibercept in chemically defined media having reduced aflibercept variants | Jul 21, 2021 | Issued |
Array
(
[id] => 20771744
[patent_doc_number] => 12655405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-16
[patent_title] => Sequence specific degradation of single-stranded polynucleotides with CARD1 nuclease
[patent_app_type] => utility
[patent_app_number] => 18/006251
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 7
[patent_no_of_words] => 6679
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006251
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006251 | Sequence specific degradation of single-stranded polynucleotides with CARD1 nuclease | Jul 18, 2021 | Issued |
Array
(
[id] => 18844413
[patent_doc_number] => 20230406817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => METHOD FOR ENZYMATIC OXIDATION OF SULFINIC ACIDS TO SULFONIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/035610
[patent_app_country] => US
[patent_app_date] => 2021-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035610
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035610 | METHOD FOR ENZYMATIC OXIDATION OF SULFINIC ACIDS TO SULFONIC ACIDS | Jul 4, 2021 | Pending |
Array
(
[id] => 17635185
[patent_doc_number] => 11345901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Acetohydroxy acid synthase variant and a microorganism comprising the same
[patent_app_type] => utility
[patent_app_number] => 17/357196
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9375
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/357196 | Acetohydroxy acid synthase variant and a microorganism comprising the same | Jun 23, 2021 | Issued |
Array
(
[id] => 18964421
[patent_doc_number] => 11898173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Recombinant acid-resistant yeast having improved lactic-acid-producing ability
[patent_app_type] => utility
[patent_app_number] => 17/353323
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17062
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353323 | Recombinant acid-resistant yeast having improved lactic-acid-producing ability | Jun 20, 2021 | Issued |